ELOXX PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $871.2K | $33.2K |
| FY2018 | — | $42.9M | $48.6M |
| FY2019 | $10.5M | $36.2M | $22.5M |
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $871.2K | $33.2K |
| FY2018 | — | $42.9M | $48.6M |
| FY2019 | $10.5M | $36.2M | $22.5M |
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |